Ionis Pharmaceuticals Inc
NASDAQ:IONS

Watchlist Manager
Ionis Pharmaceuticals Inc Logo
Ionis Pharmaceuticals Inc
NASDAQ:IONS
Watchlist
Price: 33.5 USD -2.81% Market Closed
Market Cap: 5.3B USD

Wall Street
Price Targets

IONS Price Targets Summary
Ionis Pharmaceuticals Inc

Wall Street analysts forecast IONS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IONS is 59.07 USD with a low forecast of 37.37 USD and a high forecast of 81.9 USD.

Lowest
Price Target
37.37 USD
12% Upside
Average
Price Target
59.07 USD
76% Upside
Highest
Price Target
81.9 USD
144% Upside
Ionis Pharmaceuticals Inc Competitors:
Price Targets
REGN
Regeneron Pharmaceuticals Inc
36% Upside
ZYME
Zymeworks Inc
91% Upside
DBV
DBV Technologies SA
197% Upside
BCRX
BioCryst Pharmaceuticals Inc
74% Upside
688373
Shanghai MicuRx Pharmaceutical Co Ltd
16% Downside
RAPT
Rapt Therapeutics Inc
474% Upside
CRNX
Crinetics Pharmaceuticals Inc
158% Upside
OSE
OSE Immunotherapeutics SA
169% Upside

Revenue
Forecast

Revenue Estimate
Ionis Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Ionis Pharmaceuticals Inc's revenue is 8%. The projected CAGR for the next 3 years is 20%.

8%
Past Growth
20%
Estimated Growth
Estimates Accuracy
10%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Ionis Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Net Income
Forecast

Net Income Estimate
Ionis Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IONS's stock price target?
Price Target
59.07 USD

According to Wall Street analysts, the average 1-year price target for IONS is 59.07 USD with a low forecast of 37.37 USD and a high forecast of 81.9 USD.

What is Ionis Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Ionis Pharmaceuticals Inc's revenue is 8%. The projected CAGR for the next 3 years is 20%.

Back to Top